Danimer Scientific Appoints Michael A. Hajost as Chief Financial Officer
January 20 2022 - 8:00AM
Business Wire
Jad Dowdy to assume new role of Senior Vice
President of Financial Planning and Analysis
Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the
“Company”), a leading next generation bioplastics company focused
on the development and production of biodegradable materials, today
announced the appointment of Michael (Mike) A. Hajost as Chief
Financial Officer. Hajost will succeed John A. (Jad) Dowdy, III,
who will assume the new role of Senior Vice President, Financial
Planning and Analysis. Hajost will join the Company on February 7,
2022, as special advisor to Danimer’s Chief Executive Officer
Stephen E. Croskrey before assuming the CFO position in early March
2022.
Hajost most recently served as CFO of Strategic Materials, Inc.,
one of the largest and most comprehensive glass recyclers in North
America with 900 employees across 50 locations. Prior to that
position, he served as CFO of Accuride Corporation, a global leader
in the design and manufacturing of wheel components for the
commercial truck, passenger car and off-road vehicle industries,
where he was instrumental in doubling its revenues through
strategic acquisitions. Prior to Accuride, he served as Vice
President, Treasury and Investor Relations at Carpenter Technology
Corporation (NYSE:CRS), a leading international manufacturer of
specialty alloys and engineered products. He brings a strong track
record of strategic transactions, capital market financing, risk
management and liquidity management, as well as the proven ability
to maximize growth. His experience leading financial operations and
investor relations at billion-dollar manufacturing and technology
companies will be a critical asset to Danimer as it continues to
grow its operations. Hajost’s 30-year corporate career was preceded
by his five years of service as an officer in the U.S. Army,
attaining the rank of Captain. He is a graduate of the United
States Military Academy at West Point with a Bachelor of Science
degree in Engineering. He subsequently earned his MBA in Finance
from the Booth School of Business at the University of Chicago.
Croskrey said, “Mike brings considerable experience in managing
global growth and profitability while leading the finance and
investor relations functions of several large companies across a
variety of industries. His skills and perspectives will be
instrumental in helping us maintain our leading position as a
bioplastics manufacturer during this period of industry growth, and
I’m thrilled to welcome him to Danimer. Additionally, I would like
to thank Jad for his invaluable guidance throughout Danimer’s
journey from a start-up to a public company, and I am grateful to
have his continued support as we further our growth
initiatives.”
Hajost said, “I am excited to join a talented team that is at
the forefront of this burgeoning industry. After closely following
Danimer’s work in developing PHA and other biodegradable
alternatives to plastic, I look forward to helping bring the
Company’s vision to fruition.”
Dowdy, who will continue supporting ongoing operations and
special projects such as the construction of Danimer’s new
manufacturing facility in Bainbridge, said, “I am proud of the work
we have done to grow Danimer into a public company, and we are only
just getting started. There is tremendous opportunity to build upon
the rapidly growing interest in commercial applications for
biopolymers, and I’m looking forward to working with Mike to help
execute our strategy to drive growth and meet customer demand.”
For more information, please visit
www.DanimerScientific.com.
About Danimer Scientific
Danimer is a pioneer in creating more sustainable, more natural
ways to make plastic products. For more than a decade, its
renewable and sustainable biopolymers have helped create plastic
products that are biodegradable and compostable and return to
nature instead of polluting our lands and waters. Danimer’s
technology can be found in a vast array of plastic end products
that people use every day. Applications for its biopolymers include
additives, aqueous coatings, fibers, filaments, films and
injection-molded articles, among others. Danimer holds more than
390 granted patents and pending patent applications in more than 20
countries for a range of manufacturing processes and biopolymer
formulations. For more information, visit
www.DanimerScientific.com.
Forward‐Looking Statements
Please note that in this press release we may use words such as
“appears,” “anticipates,” “believes,” “plans,” “expects,”
“intends,” “future,” and similar expressions which constitute
forward-looking statements within the meaning of the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are made based on our expectations and
beliefs concerning future events impacting the Company and
therefore involve a number of risks and uncertainties. We caution
that forward-looking statements are not guarantees and that actual
results could differ materially from those expressed or implied in
the forward-looking statements. Potential risks and uncertainties
that could cause the actual results of operations or financial
condition of the Company to differ materially from those expressed
or implied by forward-looking statements in this release include,
but are not limited to, the overall level of consumer demand on our
products; general economic conditions and other factors affecting
consumer confidence, preferences, and behavior; disruption and
volatility in the global currency, capital, and credit markets; the
financial strength of the Company's customers; the Company's
ability to implement its business strategy, including, but not
limited to, its ability to expand its production facilities and
plants to meet customer demand for its products and the timing
thereof; risks relating to the uncertainty of the projected
financial information with respect to the Company; the ability of
the Company to execute and integrate acquisitions; changes in
governmental regulation, legislation or public opinion relating to
our products; the Company’s exposure to product liability or
product warranty claims and other loss contingencies; disruptions
and other impacts to the Company’s business, as a result of the
COVID-19 global pandemic and government actions and restrictive
measures implemented in response; stability of the Company’s
manufacturing facilities and suppliers, as well as consumer demand
for our products, in light of disease epidemics and health-related
concerns such as the COVID-19 global pandemic; the impact that
global climate change trends may have on the Company and its
suppliers and customers; the Company's ability to protect patents,
trademarks and other intellectual property rights; any breaches of,
or interruptions in, our information systems; the ability of our
information technology systems or information security systems to
operate effectively, including as a result of security breaches,
viruses, hackers, malware, natural disasters, vendor business
interruptions or other causes; our ability to properly maintain,
protect, repair or upgrade our information technology systems or
information security systems, or problems with our transitioning to
upgraded or replacement systems; the impact of adverse publicity
about the Company and/or its brands, including without limitation,
through social media or in connection with brand damaging events
and/or public perception; fluctuations in the price, availability
and quality of raw materials and contracted products as well as
foreign currency fluctuations; our ability to utilize potential net
operating loss carryforwards; and changes in tax laws and
liabilities, tariffs, legal, regulatory, political and economic
risks. More information on potential factors that could affect the
Company's financial results is included from time to time in the
Company's public reports filed with the Securities and Exchange
Commission, including the Company's Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.
All forward-looking statements included in this press release are
based upon information available to the Company as of the date of
this press release, and speak only as of the date hereof. We assume
no obligation to update any forward-looking statements to reflect
events or circumstances after the date of this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220120005314/en/
For Danimer: Investors ir@danimer.com Phone:
229-220-1103
Media Anthony Popiel apopiel@daltonagency.com Phone:
404-876-1309
Danimer Scientific (NYSE:DNMR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Danimer Scientific (NYSE:DNMR)
Historical Stock Chart
From Apr 2023 to Apr 2024